You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 14, 2024

CLINICAL TRIALS PROFILE FOR HYDROCORTISONE SODIUM SUCCINATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Hydrocortisone Sodium Succinate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002757 ↗ TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma Completed Children's Cancer and Leukaemia Group Phase 3 2001-06-01 RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma.
NCT00002757 ↗ TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma Completed National Cancer Institute (NCI) Phase 3 2001-06-01 RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma.
NCT00002757 ↗ TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma Completed Societe Francaise Oncologie Pediatrique Phase 3 2001-06-01 RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma.
NCT00002757 ↗ TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma Completed Children's Oncology Group Phase 3 2001-06-01 RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Hydrocortisone Sodium Succinate

Condition Name

Condition Name for Hydrocortisone Sodium Succinate
Intervention Trials
Leukemia 5
Untreated Childhood Acute Lymphoblastic Leukemia 4
Sepsis 3
Untreated Adult Acute Lymphoblastic Leukemia 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Hydrocortisone Sodium Succinate
Intervention Trials
Leukemia 17
Leukemia, Lymphoid 16
Precursor Cell Lymphoblastic Leukemia-Lymphoma 16
Lymphoma 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Hydrocortisone Sodium Succinate

Trials by Country

Trials by Country for Hydrocortisone Sodium Succinate
Location Trials
United States 313
Canada 41
Australia 22
New Zealand 6
France 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Hydrocortisone Sodium Succinate
Location Trials
California 11
New York 10
Massachusetts 10
Ohio 10
Tennessee 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Hydrocortisone Sodium Succinate

Clinical Trial Phase

Clinical Trial Phase for Hydrocortisone Sodium Succinate
Clinical Trial Phase Trials
Phase 3 9
Phase 2/Phase 3 1
Phase 2 10
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Hydrocortisone Sodium Succinate
Clinical Trial Phase Trials
Completed 11
Active, not recruiting 5
Not yet recruiting 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Hydrocortisone Sodium Succinate

Sponsor Name

Sponsor Name for Hydrocortisone Sodium Succinate
Sponsor Trials
National Cancer Institute (NCI) 11
Children's Oncology Group 6
Therapeutic Advances in Childhood Leukemia Consortium 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Hydrocortisone Sodium Succinate
Sponsor Trials
Other 40
NIH 11
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.